{
  "docId": "019de073-a4f9-77e5-8cbf-a98a0ec20f41",
  "docSlug": "527bf315fca9a14279ec523dc4665564",
  "documentTitle": "Athira Pharma | Results Presentation Deck | 11 slides",
  "authorId": "athira-pharma",
  "authorName": "Athira Pharma",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 11,
  "prevPage": 10,
  "nextPage": null,
  "slideType": "problem_statement",
  "function": "size_opportunity",
  "density": "overcrowded",
  "nDataPoints": 6,
  "notes": "The slide uses a grid of metrics to establish the market size and the problem (lack of new treatments).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-a4f9-77e5-8cbf-a98a0ec20f41/11",
  "deckHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41",
  "deckJsonHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41.json",
  "deckAnchorHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.3,
        "x": 0.65,
        "y": 0.5
      },
      "kind": "callout",
      "text": "Significant opportunity for fosgonimeton. Limited treatment options exist today for those with Alzheimer's disease; novel approaches to improve cognition, function and neuroprotection are needed",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "05b3949c-4b11-4bf3-8998-ad65b6fb46fd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.05,
        "y": 0.4
      },
      "kind": "metric",
      "text": "Multi-Billion $ Market Despite generic entries",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23bb4c5c-04b5-4380-8f57-ae0b385dab3a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.05,
        "y": 0.6
      },
      "kind": "metric",
      "text": "Zero New marketed products since 2003",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "884e8684-0639-471e-985b-6a6774cf3b13",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "metric",
      "text": "35 million Estimated Alzheimer's cases worldwide",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a30b7f83-3f1b-4be2-8cb9-c1864a42da00",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.35,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Over 100 million globally by 2050 ~900,000 new patients diagnosed annually in the US alone",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "39880695-104d-49f0-9894-0ce19716bd21",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.65,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "6.2 million treatment eligible patients in the US in 2021 based on prevalence data Growing at 3% per year",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "882217b3-00b9-44fb-bfae-f377ffb2b374",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.35,
        "y": 0.6
      },
      "kind": "paragraph",
      "text": "Mild to Moderate comprises 81% of all patients with Alzheimer's disease",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9cc67a5b-b455-44e8-bb1b-6906319e9d1c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "1-4 references listed at bottom",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8b0ff115-9792-4479-b844-4be506d719bb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Fosgonimeton - A New Potential Therapy for Alzheimer's Disease",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bf10d7cb-538d-4627-83c6-575e4120b754",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "c6137c10-80f8-43ba-9a54-c1954003ec50",
      "evidence": "The slide presents a significant opportunity and highlights the limitations of current treatments, which is part of the AIDA model.",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 11,
      "from": 4,
      "beatId": "ec20a1da-004a-4f5b-ac24-cdc67eafb0cd",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Fosgonimeton shows promise as a new potential therapy for Alzheimer's disease",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 11,
      "from": 4,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "8b9b785b-4f0f-46be-8af5-f2f0d1f429d0",
      "evidence": "Clear presentation of study results and next steps",
      "position": 1,
      "objective": "What are the key takeaways from the Phase 2/3 LIFT-AD study?",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.7,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}